GGrantIndex
Sort

23,748 grants matching melanoma

Development of therapeutic chemokine-based formulations

$251,405
Arya Biragyn · National Institute On Aging · ZIA · FY2009 · AG

Immunohistochemical analysis of tumors

$251,384
Markku Miettinen · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

NOVEL APPROACAHES FOR IMPROVING PEDIATRIC BRAFV600E GLIOMA PATIENT OUTCOMES

$251,360
Charles David James · University Of California, San Francisco · P50 · FY2015 · CA

PVSRIPO in melanoma

$251,345
Georgia Beasley · Duke University · K08 · FY2022 · CA

Development of BBB Permeable PD-L1 PET Imaging Agents

$251,250
Zhengxin Cai · Yale University · R21 · FY2019 · EB

Naïve T cell archetypes and anti-tumor immunity

$251,250
Carla Rothlin · Yale University · R21 · FY2023 · AI

ECM MATRIX, PROTEASE AND MELANOMA PROLIFERATION

$251,139
Yves A Declerck · Children'S Hospital Of Los Angeles · R01 · FY2007 · CA

RNA-based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells

$251,093
John H Sampson · Duke University · R01 · FY2008 · CA

SOUTHWEST ONCOLOGY GROUP

$251,064
Cleveland Clinic Foundation · U10 · FY2002 · CA

Melanoma Metastasis Inhibition by Eristostatin

$251,038
University Of Delaware · R01 · FY2004 · CA

Integrative genomic analysis in hepatocellular carcinoma

$251,025
Josep M Llovet · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · DK

REGULATION OF UVEAL MELANOMA INTERCONVERTED PHENOTYPE

$251,025
University Of Iowa · R01 · FY2002 · CA

Core B - Biospecimen/Pathology Core

$250,991
Iman Osman · New York University School Of Medicine · P50 · FY2022 · CA

Core B - Biospecimen/Pathology Core

$250,990
Iman Osman · New York University School Of Medicine · P50 · FY2021 · CA

Core B - Biospecimen/Pathology Core

$250,989
Iman Osman · New York University School Of Medicine · P50 · FY2019 · CA

Administrative Core

$250,959
Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA

Update of the WTC Cancer Tissue Biobank

$250,953
Emanuela Taioli · Icahn School Of Medicine At Mount Sinai · R21 · FY2025 · OH

DFMO Prevention Study (2b) in Organ Transplant Subjects

$250,945
University Of Wisconsin Madison · R01 · FY2002 · CA

PERTURBATION OF HYALURONAN FUNCTION IN CANCER

$250,885
Medical University Of South Carolina · R01 · FY2003 · CA

Generation of T-cell receptors recognizing antigens on non-melanoma tumors

$250,875
James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

TRANSLATIONAL RESEARCH IN CANCER

$250,867
Thomas Jefferson University · P30 · FY2000 · CA

Biostatistics Core

$250,796
Phyllis A Gimotty · Wistar Institute · P50 · FY2017 · CA

Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology

$250,795
David Liu · Dana-Farber Cancer Inst · K08 · FY2020 · CA

Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology

$250,795
David Liu · Dana-Farber Cancer Inst · K08 · FY2022 · CA

Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology

$250,795
David Liu · Dana-Farber Cancer Inst · K08 · FY2021 · CA